In the midst of the COVID-19 outbreak, Dr. Tae Han Kim, the founder and CEO of Samsung Biologics, and his team proved that it’s possible to protect both the health of its workforce and clients, while also ensuring the company meets the continuous business operations, client demands, and production schedules without delay. Samsung Biologics is […]
License and Republishing: The views expressed in this article CEO Spotlight: Samsung Biologics’ CEO Dr. Tae Han Kim Talks Response to COVID-19, Future Vision are those of the author Sophie Ireland alone and not the CEOWORLD magazine. You can’t reproduce, republish, or reprint it without the express permission of the CEOWORLD magazine.
This post was originally published on this site